{"columns": ["cmem_n_edit_distance", "cmem_n_is_updated", "cmem_n_memory_len", "cmem_n_memory_str", "cmem_n_memory_str_len"], "data": [[NaN, NaN, 9.0, "1. N stage is determined by the number of lymph nodes involved and the presence of extracapsular extension.\n2. N0: No regional lymph node metastasis.\n3. N1: Metastasis in 1-3 axillary lymph nodes or in internal mammary nodes with clinically negative axillary nodes.\n4. N2: Metastasis in 4-9 axillary lymph nodes or in clinically detected internal mammary nodes in the absence of axillary lymph node metastasis.\n5. N3: Metastasis in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral supraclavicular lymph nodes.\n6. Extracapsular extension of tumor in lymph nodes increases the N stage.\n7. The N stage should be determined based on the number of examined lymph nodes and the presence of metastasis.\n8. AJCC staging system should be followed for consistent staging.\n9. Avoid using report-specific information for rule creation.", 844.0], [79.0, false, 9.0, "1. N stage is determined by the number of lymph nodes involved and the presence of extracapsular extension.\n2. N0: No regional lymph node metastasis.\n3. N1: Metastasis in 1-3 axillary lymph nodes or in internal mammary nodes with clinically negative axillary nodes.\n4. N2: Metastasis in 4-9 axillary lymph nodes or in clinically detected internal mammary nodes in the absence of axillary lymph node metastasis.\n5. N3: Metastasis in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral supraclavicular lymph nodes.\n6. Extracapsular extension of tumor in lymph nodes increases the N stage.\n7. The N stage should be determined based on the number of examined lymph nodes and the presence of metastasis.\n8. AJCC staging system should be followed for consistent staging.\n9. Avoid using report-specific information for rule creation.", 844.0], [95.0, true, 10.0, "1. N stage is determined by the number of lymph nodes involved and the presence of extracapsular extension.\n2. N0: No regional lymph node metastasis.\n3. N1: Metastasis in 1-3 axillary lymph nodes or in internal mammary nodes with clinically negative axillary nodes.\n4. N2: Metastasis in 4-9 axillary lymph nodes or in clinically detected internal mammary nodes in the absence of axillary lymph node metastasis.\n5. N3: Metastasis in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral supraclavicular lymph nodes.\n6. Extracapsular extension of tumor in lymph nodes increases the N stage.\n7. The N stage should be determined based on the number of examined lymph nodes and the presence of metastasis.\n8. AJCC staging system should be followed for consistent staging.\n9. Avoid using report-specific information for rule creation.\n10. The absence of lymph node metastasis in examined lymph nodes corresponds to N0.", 928.0], [93.0, true, 11.0, "1. N stage is determined by the number of lymph nodes involved and the presence of extracapsular extension.\n2. N0: No regional lymph node metastasis.\n3. N1: Metastasis in 1-3 axillary lymph nodes or in internal mammary nodes with clinically negative axillary nodes.\n4. N2: Metastasis in 4-9 axillary lymph nodes or in clinically detected internal mammary nodes in the absence of axillary lymph node metastasis.\n5. N3: Metastasis in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral supraclavicular lymph nodes.\n6. Extracapsular extension of tumor in lymph nodes increases the N stage.\n7. The N stage should be determined based on the number of examined lymph nodes and the presence of metastasis.\n8. AJCC staging system should be followed for consistent staging.\n9. Avoid using report-specific information for rule creation.\n10. The absence of lymph node metastasis in examined lymph nodes corresponds to N0.\n11. N3 is met when there are metastases in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral supraclavicular lymph nodes.", 1070.0], [93.0, true, 12.0, "1. N stage is determined by the number of lymph nodes involved and the presence of extracapsular extension.\n2. N0: No regional lymph node metastasis.\n3. N1: Metastasis in 1-3 axillary lymph nodes or in internal mammary nodes with clinically negative axillary nodes.\n4. N2: Metastasis in 4-9 axillary lymph nodes or in clinically detected internal mammary nodes in the absence of axillary lymph node metastasis.\n5. N3: Metastasis in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral supraclavicular lymph nodes.\n6. Extracapsular extension of tumor in lymph nodes increases the N stage.\n7. The N stage should be determined based on the number of examined lymph nodes and the presence of metastasis.\n8. AJCC staging system should be followed for consistent staging.\n9. Avoid using report-specific information for rule creation.\n10. The absence of lymph node metastasis in examined lymph nodes corresponds to N0.\n11. N3 is met when there are metastases in 10 or more axillary lymph nodes or in inframammary and/or ipsilateral supraclavicular lymph nodes.\n12. N2 is met when there are metastases in 4-9 axillary lymph nodes or in clinically detected internal mammary nodes in the absence of axillary lymph node metastasis.", 1237.0]]}